(Q54444156)

29 May 2018

title

Dual actions of sulfonylureas and glyburide. Receptor and post-receptor effects. (English)

1 reference

29 May 2018

author name string

Gavin JR 3rd

series ordinal

1

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 September 1985

1 reference

29 May 2018

American Journal of Medicine

published in

1 reference

29 May 2018

volume

79

1 reference

29 May 2018

issue

3B

1 reference

29 May 2018

page(s)

34-42

1 reference

29 May 2018

Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

An insulin dependent effect of chronic tolbutamide administration on the skeletal muscle carbohydrate transport system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Sulphonylureas increase the number of insulin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Extrapancreatic action of sulphonylureas: effect of gliquidone on insulin and glucagon binding to rat liver plasma membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Direct in vitro effect of a sulfonylurea to increase human fibroblast insulin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Effects of tolbutamide on insulin binding to isolated fat cells of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Sulphonylureas in vitro do not alter insulin binding or insulin effect on amino acid transport in rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Modulation by a sulfonylurea of insulin-dependent glycogenesis, but not of insulin binding, in cultured rat hepatocytes. Evidence for a postreceptor mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

The effect of glibenclamide on insulin receptors in normal man: comparative studies of insulin binding to monocytes and erythrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Determination of glyburide in human serum by liquid chromatography with fluorescence detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Improved insulin receptor assay: effects of an antidiabetic sulphonylurea on liver membrane insulin receptors from obese hyperglycaemic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Sulfonylureas do not affect insulin binding or glycemic control in insulin-dependent diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Comparison of the in vitro effect of biguanides and sulfonylureas on insulin binding of its receptors in target cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Potentiation of Insulin Action by a Sulfonylurea in Primary Cultures of Hepatocytes from Normal and Diabetic Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Potentiation of the Hepatic Action of Insulin by Chlorpropamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Insulin-like and insulin-enhancing effects of the sulfonylurea glyburide on rat adipose glycogen synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Characterization of a unique muscle cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Islet Secretion in a New Experimental Model for Non-insulin-dependent Diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Impaired insulin action in rats with non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Insulin receptor defect in insulin resistance: studies in the obese-hyperglycimic mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2885%2980005-X

10.1016/S0002-9343(85)80005-X

7 January 2021

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

3931460

1 reference

29 May 2018